Elsevier

Bone

Volume 116, November 2018, Pages 232-247
Bone

Full Length Article
Osteoblast derived-neurotrophin‑3 induces cartilage removal proteases and osteoclast-mediated function at injured growth plate in rats

https://doi.org/10.1016/j.bone.2018.08.010Get rights and content

Highlights

  • Injury site osteoblast-derived NT-3 has both direct and indirect roles in promoting growth plate injury site remodeling.

  • NT-3 enhances expression of MMP-9 and MMP-13 and osteoclast recruitment and function at the growth plate injury site.

  • NT-3 was induced in mineralizing BMSCs, and the conditioned medium augmented osteoclastogenesis and resorptive activity.

  • NT-3 can induce osteoclastogenic cytokines and RANKL in osteoblasts.

  • NT-3 and TrkC were induced, and rhNT-3 treatment activated TrkC downstream kinase Erk1/2 in differentiating osteoclasts.

Abstract

Faulty bony repair causes dysrepair of injured growth plate cartilage and bone growth defects in children; however, the underlying mechanisms are unclear. Recently, we observed the prominent induction of neurotrophin‑3 (NT-3) and its important roles as an osteogenic and angiogenic factor promoting the bony repair. The current study investigated its roles in regulating injury site remodelling. In a rat tibial growth plate drill-hole injury repair model, NT-3 was expressed prominently in osteoblasts at the injury site. Recombinant NT-3 (rhNT-3) systemic treatment enhanced, but NT-3 immunoneutralization attenuated, expression of cartilage-removal proteases (MMP-9 and MMP-13), presence of bone-resorbing osteoclasts and expression of osteoclast protease cathepsin K, and remodelling at the injury site. NT-3 was also highly induced in cultured mineralizing rat bone marrow stromal cells, and the conditioned medium augmented osteoclast formation and resorptive activity, an ability that was blocked by presence of anti-NT-3 antibody. Moreover, NT-3 and receptor TrkC were induced during osteoclastogenesis, and rhNT-3 treatment activated TrkC downstream kinase Erk1/2 in differentiating osteoclasts although rhNT-3 alone did not affect activation of osteoclastogenic transcription factors NF-κB or NFAT in RAW264.7 osteoclast precursor cells. Furthermore, rhNT-3 treatment increased, but NT-3 neutralization reduced, expression of osteoclastogenic cytokines (RANKL, TNF-α, and IL-1) in mineralizing osteoblasts and in growth plate injury site, and rhNT-3 augmented the induction of these cytokines caused by RANKL treatment in RAW264.7 cells. Thus, injury site osteoblast-derived NT-3 is important in promoting growth plate injury site remodelling, as it induces cartilage proteases for cartilage removal and augments osteoclastogenesis and resorption both directly (involving activing Erk1/2 and substantiating RANKL-induced increased expression of osteoclastogenic signals in differentiating osteoclasts) and indirectly (inducing osteoclastogenic signals in osteoblasts).

Introduction

Childhood bone fractures are common with about 50% of children and adolescents unfortunately experiencing a bone fracture [1]. Located at the weakest part of a long bone, the growth plate cartilage (which is responsible for bone growth) is highly prone to injuries (involved in 20% of all fractures) [2]. Yet, the injured growth plate is often “undesirably” repaired by bony tissue, causing bone growth defects (limb length discrepancy and angulations). Currently, correction of these bone defects relies on extremely invasive and sometimes ineffective surgical procedures, and there is a strong need to gain mechanistic understanding underlying the “faulty” repair and develop a preventive treatment [3]. Although previous work in animal models of growth plate repair has identified repair responses (inflammatory, fibrogenic, osteogenic and remodelling) and of some molecular pathways involved [[3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18]], mechanisms for the faulty repair still require further elucidation.

In a recent study, neurotrophin‑3 (NT-3) and its high affinity receptor TrkC were found to be highly induced at the injury site and endogenous NT-3 was found to promote bony repair [18]. Increasing evidence now suggests that, apart from their known functions regulating the development/maintenance of the nervous system, neurotrophins or NTs [including nerve growth factor (NGF), brain-derived growth factor (BDNF), neurotrophin-3 (NT-3) and NT-4] and their receptors [including their common low-affinity p75 receptor and specific high-affinity Trk receptors (TrkA for NGF, TrkB for BDNF & NT-4, and TrkC for NT-3)], also have roles in the bone and cartilage as well as skeletal repair events [[18], [19], [20]]. NTs and receptors are expressed in bones [21] and bone repair cells [18,22,23]. Local application of NGF promoted bone healing [24,25]. Recently, in a rat tibial growth plate and bone injury model, we observed increased mRNA expression for neurotrophins NGF, BDNF, NT-3 and NT-4 and their Trk receptors (with NT-3 and its receptor TrkC showing the highest induction) at injury site [18]. Furthermore, NT-3 has been shown to induce the critical osteogenic factor bone morphogenetic protein (BMP-2) and key angiogenic factor vascular endothelial growth factor (VEGF), and NT-3 was found to promote bone formation and vascularization and thus bony repair at the injured growth plate. However, it remains unknown whether and how the injury site-induced NT-3 is involved in regulating the growth plate injury site remodelling.

Previous studies in rat models demonstrated that bony repair at the injured growth plate involves both cartilage and bone formation and osteoclastic remodelling of the newly formed bone trabeculae at the injury site [8,9,12]. During skeletal repair injury site remodelling, cartilage tissue initially formed needs to be removed by osteoclast/chondroclast-mediated resorption and/or degradation by cartilage proteases collagenase-3 (MMP-13) and gelatinase-9 (MMP-9) [26,27]. Then, the initial bone formed and bone converted from cartilage tissue require further remodelling (by resorption and bone formation) [26,28]. Skeletal repair events are known to be tightly regulated by locally produced molecules, such as inflammatory cytokines, osteogenic factors (particularly BMPs [29]), angiogenic factors (particularly VEGF [30]), and osteoclastogenesis regulators [including the major osteoclastogenesis stimulator RANKL (receptor activator of nuclear factor kappa-B ligand) and inhibitor osteoprotegerin (OPG)] [31]. Evidence is emerging that remodelling of the skeletal injury sites is orchestrated by crosstalk between osteoclast precursors/osteoclasts and repair cells (osteoblasts and chondrocytes, which produce cross-talking signals [26,28]). However, further work is required to identify and characterise cross-talk signals that regulate skeletal repair and injury site remodelling.

The current study investigated potential functions and action mechanisms of injury site-derived NT-3 in injury site remodelling in a rat proximal tibial growth plate repair model and in in vitro models of osteoclastogenesis and resorption.

Section snippets

Rat drill-hole growth plate injury and NT-3 intervention treatments

To investigate roles of NT-3 in injury site remodelling during growth plate injury repair, a proximal tibial drill-hole growth plate injury model was used in both hind legs of 6-week-old male normal Sprague Dawley rats as described [6], with approval from the Animal Ethics Committee of SA Pathology/CHN (South Australia). On days 3 and 7 after injury, some injured rats received intraperitoneal injection of a normal sheep serum IgG or a sheep neutralising anti-NT-3 serum IgG [32] (both at 1 mg/kg

Results

To examine potential effects on the non-injured areas/bones of the systemic treatment with rhNT-3 or the anti-NT-3, further analyses of micro-computer tomography (μ-CT) data [18] at the non-injured areas of tibia metaphysis were performed. Results showed that systemic treatment with rhNT-3 or the anti-NT-3 had no significant effects in altering the trabecular bone volume fraction and trabecular structural parameters (trabecular number, thickness and separation) at both day 10 and day 28

Discussion

Mechanisms for the faulty bony repair and bone bridge formation at injured growth plate cartilage remain largely unclear. In a recent study, NT-3 and its receptor TrkC were found to highly induced, and NT-3 was found to enhance osteogenesis and angiogenesis and promote the bony repair at the growth plate injury site [18]. In the current study, we demonstrated that injury site-derived NT-3 participates in the injury site remodelling. We demonstrated that NT-3 is important for the growth plate

Disclosure

All authors state that they have no conflicts of interest.

Acknowledgements

This work was funded in parts by project grants from the National Health and Medical Research Council (NHMRC Australia) (Nos. 1043426 and 1127396), Channel-7 Children's Research Foundation of South Australia (No. 151051), and Natural Science Foundation of China (No. 81671928). Yu-Wen Su was supported by University of South Australia President's PhD Scholarship, and Cory J. Xian was funded by NHMRC Senior Research Fellowship (No. 1042105).

Author contributions

Study design: YS, XZ and CX. Study conduct: YS. Data collection: YS, SC, LZ, RC, CF, YP, QT, and MH. Data analysis: YS and CX. Data interpretation: YS, SC, BF, LB, SG, DC, YX, LC, CP, XZ, JX, and CX. Drafting manuscript: YS and CX. Revising manuscript content: YS, SC, XZ, JX, and CX. Approving final version of manuscript: YS, SC, LZ, RC, CF, MH, YP, QT, LB, SG, DC, YX, LC, BF, CP, XZ, JX, and CX. YS and CX take responsibility for the integrity of the data analysis.

References (49)

  • R. Marsell et al.

    The role of endogenous bone morphogenetic proteins in normal skeletal repair

    Injury

    (2009)
  • S.M. Chim et al.

    Angiogenic factors in bone local environment

    Cytokine Growth Factor Rev.

    (2013)
  • T.J. King et al.

    Methotrexate chemotherapy promotes osteoclast formation in the long bone of rats via increased pro-inflammatory cytokines and enhanced NF-κB activation

    Am. J. Pathol.

    (2012)
  • K.R. Georgiou et al.

    Attenuated Wnt/b-catenin signalling mediates methotrexate chemotherapy-induced bone loss and marrow adiposity in rats

    Bone

    (2012)
  • Y.K. Zhai et al.

    Icariin stimulates the osteogenic differentiation of rat bone marrow stromal cells via activating the PI3K-AKT-eNOS-NO-cGMP-PKG

    Bone

    (2014)
  • T.H. Vu et al.

    MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes

    Cell

    (1998)
  • F. Hemingway et al.

    RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II

    Bone

    (2011)
  • B.D. Carter et al.

    Neurotrophins live or let die: does p75NTR decide?

    Neuron

    (1997)
  • I.E. Jones et al.

    How many children remain fracture-free during growth? A longitudinal study of children and adolescents participating in the Dunedin Multidisciplinary Health and Development Study

    Osteoporos. Int.

    (2002)
  • T. Mizuta et al.

    Statistical analysis of the incidence of physeal injuries

    J. Pediatr. Orthop.

    (1987)
  • R. Chung et al.

    Recent research on the growth plate: mechanisms for growth plate injury repair and potential cell-based therapies for regeneration

    J. Mol. Endocrinol.

    (2014)
  • M.A. Lee et al.

    Ultilization of a murine model to investigate the molecular process of transphyseal bone formation

    J. Pediatr. Orthop.

    (2000)
  • J.M. Wattenbarger et al.

    Physeal fractures, part I: histologic features of bone, cartilage, and bar formation in a small animal model

    J. Pediatr. Orthop.

    (2002)
  • G. Arasapam et al.

    Roles of COX-2 and iNOS in the bony repair of the injured growth plate cartilage

    J. Cell. Biochem.

    (2006)
  • Cited by (18)

    • Engineered extracellular vesicles: Regulating the crosstalk between the skeleton and immune system

      2022, Engineered Regeneration
      Citation Excerpt :

      This results in limited skeletal growth and eventually lead to limb length discrepancies and long-angle deformities. The synthesis and breakdown of massive ECM in growth plates triggers an inflammatory response after injury [103]. Therefore, we need to modulate the local immune microenvironment after injury.

    • Exosome-loaded extracellular matrix-mimic hydrogel with anti-inflammatory property Facilitates/promotes growth plate injury repair

      2022, Bioactive Materials
      Citation Excerpt :

      The direct loss of a large amount of ECM after growth plate injuries and excessive inflammation can disrupt the ECM synthesis and decomposition balance. After an injury, an inflammatory response is triggered to regulate downstream remodeling and repair events [7]. These large number of inflammatory factors accelerate the degradation of ECM and stimulate the damaged chondrocytes to produce matrix metalloproteinases (MMPs), all while inhibiting the expression of cartilage matrix protein genes (SOX-9), further aggravating the catabolism of chondrocytes ECM [8].

    • Enhanced BMP signalling causes growth plate cartilage dysrepair in rats

      2021, Bone
      Citation Excerpt :

      For the control groups, uninjured growth plate tissues from rats aged 7 weeks (Day 14 after injury) and 10 weeks (Day 35 after injury) were used. Immunohistochemical analysis was performed on the growth plate sections as described [14]. Briefly, deparaffinized tissue sections were rehydrated through sequential ethanol washes and quenched in 3% H2O2.

    • Osteoclast differentiation and formation induced by titanium implantation through complement C3a

      2021, Materials Science and Engineering C
      Citation Excerpt :

      C3-convertase cleaves and activates component C3, generating C3a and C3b. Both of C3a and C3b mediate inflammatory responses of the local tissue after biomaterial implantation [14,29] Transcriptional factors, NF-kB and NFAT are responsible for the inflammatory cytokine expression in the osteoclast of bone tissue [30]. Our data show that the C3a, but no C3b is actively and predominantly involved in the osteoclast formation in vitro.

    • Upregulation of circulating inflammatory biomarkers under the influence of periodontal disease in rheumatoid arthritis patients

      2020, Cytokine
      Citation Excerpt :

      Although most cytokines have pleiotropic effects, their osteolytic effects are highly relevant to consider. CSF-1, TWEAK, NT-3, OSM, LIF, TRAIL, CX3CL1 and MCP-1 are capable of exerting direct and/or indirect effects on osteoclast formation and activation [40–47]. Fibroblast growth factor 19 (FGF19) known to regulate gluconeogenesis and bile salt synthesis, is increased in serum levels of patients with extrahepatic obstructive cholestasis or renal diseases [48,49].

    View all citing articles on Scopus
    1

    Current address: Department of Developmental Biology, Harvard University School of Dental Medicine, Boston, MA 02115, USA.

    View full text